No Data
Shanhe Pharmaceutical Excipients (300452): Steady Growth in Performance with Outstanding Performance in Overseas Business and Cellulose Core Categories
Event: The company released its 2025 annual report and Q1 2026 earnings report. In 2025, revenue reached 943 million yuan (year-over-year increase of 6.82%), with net profit attributable to shareholders at 177 million yuan (year-over-year increase of 47.84%). Non-recurring net profit was...
Shanhe Pharmaceutical Excipients: First Quarter Report for 2026
Shanhe Pharmaceutical Excipients: 2025 Annual Report
Shanhe Pharmaceutical Excipients: Summary of the 2025 Annual Report
Express News | The CSI Convertible Bond Index opened 0.2% higher. N Aohongzhuan and Shuangle Convertible Bonds surged 30% on their first day of listing, triggering a temporary trading halt. Jin 05 Convertible Bond rose nearly 10%, while Huachen Convertible Bond gained o
Express News | Shanhe Pharmaceutical Excipients: Estimated net profit growth of 38.16%-62.45% year-on-year for 2025.